Publications by authors named "Jun Sawa"

Claim this Profile
E
Efficacy and safety of finerenone in individuals with type 2 diabetes mellitus complicated by diabetic kidney disease: A retrospective observational study.
Yuji Kawaguchi, Yuriko Hajika, Narumi Ashida, Maho Rinka, Chie Hamai, Jun Sawa

Metabol Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring.
Yuji Kawaguchi, Yuriko Hajika, Maho Rinka, Koji Masumoto, Jun Sawa

J Diabetes Investig· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: Letter to the Editor Regarding Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.
Yuji Kawaguchi, Yuriko Hajika, Narumi Ashida, Koji Masumoto, Jun Sawa

Adv Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.
Yuji Kawaguchi, Shoko Miyamoto, Yuriko Hajika, Narumi Ashida, Tomoe Hirota, Jun Sawa

Adv Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparisons of efficacy and safety in insulin glargine and lixisenatide plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type 2 diabetes.
Yuji Kawaguchi, Shoko Miyamoto, Yuriko Hajika, Narumi Ashida, Koji Masumoto, Jun Sawa

J Diabetes Investig· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose Monitoring.
Yuji Kawaguchi, Jun Sawa, Yasuro Kumeda

Diabetes Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficacy and safety of insulin degludec/aspart (twice-daily injections), insulin glargine 300 U/mL, and insulin glulisine (basal-bolus therapy).
Yuji Kawaguchi, Jun Sawa, Chie Hamai, Yuri Nishimura, Yasuro Kumeda

J Diabetes Investig· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec.
Yuji Kawaguchi, Jun Sawa, Chie Hamai, Yasuro Kumeda

Diabetes Ther· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open-label, cross-over study using continuous glucose monitoring profiles.
Yuji Kawaguchi, Jun Sawa, Noriko Sakuma, Yasuro Kumeda

J Diabetes Investig· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.
Noritsugu Wada, Katsuhito Mori, Chie Nakagawa, Jun Sawa, Yasuro Kumeda

J Diabetes Complications· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis